STOCK TITAN

MediWound: Rosalind reports about 8.09% in common shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

MediWound Ltd. (MDWD) is the issuer in an amended Schedule 13G reporting shared ownership by Rosalind Advisors, Inc., Rosalind Master Fund L.P., Steven Salamon and Gilad Aharon. Rosalind Advisors is the fund’s investment advisor; Salamon is its president and a portfolio manager, and Aharon is a portfolio manager and member of the advisor.

The cover pages each report 1,312,319 shares, or 9.1%, including 1,149,054 common shares and 163,265 shares issuable upon warrant exercise. These are overlapping reports of the same position, not separate holdings. The filing says the common shares represent approximately 8.09%; exercise of the warrants is subject to a 9.99% ownership blocker, so actual beneficial ownership after applying the blocker is below the cover-page amount. The reported percentage uses 14,210,217 shares outstanding as of November 5, 2026. Rosalind Advisors and Salamon disclaim beneficial ownership of the shares held by the fund.

Reported beneficial ownership 1,312,319 shares Cover pages report this amount for each reporting person; it includes 163,265 shares issuable upon warrant exercise and does not give effect to the blocker.
Common shares attributed to the fund 1,149,054 shares Described as approximately 8.09% of common stock.
Shares issuable upon warrant exercise 163,265 shares Included in the cover-page amount; subject to the 9.99% ownership blocker.
Cover-page ownership percentage 9.1% Reported using 14,210,217 shares outstanding as of November 5, 2026.
Common shares outstanding 14,210,217 shares As of November 5, 2026.
Warrant ownership blocker 9.99% Warrants may not be exercised to the extent exercise would result in beneficial ownership above this percentage.
beneficial ownership regulatory
"beneficial ownership of 1,149,054 shares of common stock"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
blocker provision regulatory
"because they contain a blocker provision"
shared voting power regulatory
"Shared Voting Power 1,312,319.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared Dispositive Power 1,312,319.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MDWD shares did the Rosalind reporting persons report owning?

The cover pages each report 1,312,319 shares, or 9.1%, as the same shared position. That amount includes 1,149,054 common shares and 163,265 shares issuable upon warrant exercise; the 1,149,054 common shares are described as approximately 8.09%.

What is the warrant ownership blocker in the MDWD Schedule 13G amendment?

The warrants cannot be exercised to the extent that exercise would cause the holder’s beneficial ownership to exceed 9.99% of MDWD common stock. The filing states that the actual beneficial ownership after applying the blocker is less than the cover-page amount, which includes the warrant shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





M68830104

(CUSIP Number)
11/05/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: This percentage is calculated based upon 14,210,217 shares of the Issuers common stock outstanding as of November 5th, 2026, in accordance with Issuer's 424B5 prospectus filed on November 5th, 2026. However, as more fully described in Item 4, the securities reported in rows 6, 8, and 9 show the number of shares of Common Stock that would be issuable upon full conversion and exercise of such reported securities and do not give effect to such blockers. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows 6, 8, and 9. (6) 1,149,054 shares of Common Stock 163,265 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 1,149,054 shares of Common Stock 163,265 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 1,149,054 shares of Common Stock 163,265 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 1,149,054 shares of Common Stock 163,265 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G



Rosalind Advisors, Inc.
Signature:Steven Salamon
Name/Title:President
Date:11/13/2026
SALAMON STEVEN A J
Signature:Steven Salamon
Name/Title:Steven Salamon
Date:11/13/2026
Aharon Gil
Signature:Gil Aharon
Name/Title:Gil Aharon
Date:11/13/2026
Rosalind Master Fund L.P.
Signature:Mike McDonald
Name/Title:Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:11/13/2026

Keep reading